Quarterly report [Sections 13 or 15(d)]

Fair Value of Financial Instruments (Tables)

v3.25.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Summery of Fair Value Assets Measured On Recurring Basis

The following table summarizes cash equivalents, marketable securities and contingent consideration measured at their fair value on a recurring basis as of June 30, 2025 and December 31, 2024:

 

 

 

Fair Value Measurements as of June 30, 2025:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

   Money market funds

 

$

43,316,602

 

 

$

 

 

$

 

 

$

43,316,602

 

Total

 

$

43,316,602

 

 

$

 

 

$

 

 

$

43,316,602

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities, available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

   U.S. Treasury obligations

 

$

9,923,100

 

 

$

 

 

$

 

 

$

9,923,100

 

Total

 

$

9,923,100

 

 

$

 

 

$

 

 

$

9,923,100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration (see Note 10)

 

$

 

 

$

 

 

$

2,912,159

 

 

$

2,912,159

 

Total

 

$

 

 

$

 

 

$

2,912,159

 

 

$

2,912,159

 

 

 

 

 

Fair Value Measurements as of December 31, 2024:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

   Money market funds

 

$

11,238,598

 

 

$

 

 

$

 

 

$

11,238,598

 

Total

 

$

11,238,598

 

 

$

 

 

$

 

 

$

11,238,598

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities, available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

   U.S. Treasury obligations

 

$

41,052,949

 

 

$

 

 

$

 

 

$

41,052,949

 

Total

 

$

41,052,949

 

 

$

 

 

$

 

 

$

41,052,949

 

Summary of contingent consideration related to acquisition

The following table provides a rollforward of the contingent consideration related to the acquisition of CorHepta (see Note 10):

 

 

 

Three months ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Balance, beginning

 

$

3,270,579

 

 

$

 

 

$

 

 

$

 

Additions

 

 

 

 

 

 

 

 

4,435,443

 

 

 

 

Payments

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value

 

 

(358,420

)

 

 

 

 

 

(1,523,284

)

 

 

 

Balance, ending

 

$

2,912,159

 

 

$

 

 

$

2,912,159

 

 

$